Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for prevention of postoperative ICU delirium in elderly patients
PACTR202605474198292Phase 4Not yet recruiting
- Sponsor
- Menoufia University
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in delirium (3 arms), sponsored by Menoufia University. Primary endpoint: Incidence of delirium during the first 5 days of ICU stay. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on PACTR202605474198292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605474198292.